XML 17 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Nov. 29, 2015
Nov. 30, 2014
Cash flows from operating activities:    
Consolidated net income $ 4,916 $ 5,671
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,339 3,343
Stock-based compensation expense 1,697 748
Tax benefit from stock-based compensation expense (90) (36)
Deferred taxes 1,167 1,415
Change in investment in non-public company, fair value (1,000) (1,400)
Changes in current assets and current liabilities:    
Accounts receivable, net (3,804) (7,573)
Inventories, net (3,832) (5,705)
Issuance of notes and advances receivable (621) (2,464)
Collection of notes and advances receivable 249 363
Prepaid expenses and other current assets (2,092) 2,056
Accounts payable 1,912 $ 7,401
Income taxes payable (702)
Accrued compensation (1,359) $ 877
Other accrued liabilities 1,874 (303)
Deferred revenue (462) (1,043)
Net cash provided by operating activities 2,192 3,350
Cash flows from investing activities:    
Purchases of property and equipment (15,203) $ (7,135)
Deposit on capital lease (850)
Proceeds from sale of fixed assets $ 91
Investment in non-public company, fair value $ (18,000)
Net cash used in investing activities $ (15,962) (25,135)
Cash flows from financing activities:    
Proceeds from sale of common stock $ 108 100
Taxes paid by Company for stock swaps and RSUs (12)
Tax benefit from stock-based compensation expense $ 90 36
Proceeds from long-term debt 9,972 11,194
Payments on long-term debt (4,278) (3,341)
Proceeds from lines of credit 10,500 25,117
Payments on lines of credit (10,500) (20,117)
Change in other assets (26) (269)
Payments to non-controlling interest holders (248) (196)
Net cash provided by financing activities 5,618 12,512
Net decrease in cash and cash equivalents (8,152) (9,273)
Cash and cash equivalents at beginning of period 14,127 [1] 14,243
Cash and cash equivalents at end of period $ 5,975 $ 4,970
[1] Derived from audited financial statements.